NervGen Pharma Corp. (NGEN.V) TSXV

3.28

-0.12(-3.53%)

Updated at September 26 03:58PM

Currency In CAD

Valuation

Market Cap211.39M
Enterprise Value194.23M
P/E Ratio-8.78
PEG Ratio1.58
Price/Sales Ratio0
Price/Book Ratio-256.98
Enterprise/Revenue0
Enterprise/EBITDA-8.51

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.59
Return On Equity-8.8

Income Statement

Revenue0
Revenue/Share0
Gross Profit-83,798
EBITDA-23.92M
Net Income-24.01M
Diluted EPS-0.36

Balance Sheet

Total Cash15.73M
Total Cash/Share0.22
Total Debt57,713
Total Debt/Equity-0.06
Current Ratio0.92
Book Value Per Share-0.01

Price History

52-Week Change27.63
52-Week High7.05
52-Week Low2.05
Moving Average 50 Days3.45
Moving Average 200 Days3.32

Statistics

Average Volume71,901
Shares Outstanding73.28M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A